Blood Cancer United®, formerly The Leukemia & Lymphoma Society, is proud to kick-off of its annual iconic philanthropic ...

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...

BEXAR COUNTY, Texas – Anyone who is diagnosed with a form of blood cancer has likely been there before. It can feel isolating, as if no one else can relate to them or can help at all. In terms of ...

SAN ANTONIO – Thanks to efforts from doctors, researchers, health care providers and nonprofits such as Blood Cancer United, certain types of blood cancers are no longer the terminal diagnoses that ...

Student Visionaries are motivated, purpose-driven high school students, passionate about making a difference. Each year, these young leaders embark on an exciting 7-week journey with a clear goal: to ...

Joey Carlsen Martinez was treated at MSK for Erdheim-Chester disease, a rare form of blood cancer. He received an experimental drug called ulixertinib as part of a single-patient clinical trial. The ...

Pivekimab sunirine (PVEK) targets CD123, showing promise in treating BPDCN, a rare aggressive blood cancer with limited treatment options. The CADENZA trial reported a 70% complete remission rate in ...

Nuvisertib received FDA fast track designation for myelofibrosis, showing significant clinical activity in symptom and spleen response, and improvements in bone marrow fibrosis, hemoglobin, and ...

Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...